Progesterone and sleep are linked through neuroendocrine pathways. Progesterone and its metabolite allopregnanolone act as positive allosteric modulators of GABA-A receptors, promoting sedation, anxiolysis, and sleep. Natural fluctuations—such as the drop in progesterone during the late luteal phase or menopause—are associated with increased insomnia risk. Some clinical studies report that progesterone supplementation (oral or transdermal) can improve sleep onset and deep sleep, especially in women with low endogenous levels. However, the evidence is moderate: many studies are small, lack placebo controls, or show inconsistent results. Synthetic progestins may not share the same sleep benefits. Genetic variants in progesterone receptors (e.g., PGR) are not yet actionable for sleep management. A conservative approach: if sleep problems persist, consult a physician for a full workup before considering hormone therapy. Consumer DNA tests cannot reliably predict progesterone-related sleep issues.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-c5c6e4e79ae78d2f289938b9